These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 206274

  • 1. alpha1-Antitrypsin deficiency and hepatocellular cancer.
    Kew MC, Turnbull R, Prinsloo I.
    Br J Cancer; 1978 Apr; 37(4):635-8. PubMed ID: 206274
    [No Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma in a 12-year-old child with PiZZ alpha1-antitrypsin deficiency.
    Hadzic N, Quaglia A, Mieli-Vergani G.
    Hepatology; 2006 Jan; 43(1):194. PubMed ID: 16374862
    [No Abstract] [Full Text] [Related]

  • 3. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma.
    Rabinovitz M, Gavaler JS, Kelly RH, Prieto M, Van Thiel DH.
    Hepatology; 1992 Mar; 15(3):407-10. PubMed ID: 1312055
    [Abstract] [Full Text] [Related]

  • 4. Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ).
    Rawlings W, Moss J, Cooper HS, Hamilton SR.
    Ann Intern Med; 1974 Dec; 81(6):771-3. PubMed ID: 4372920
    [No Abstract] [Full Text] [Related]

  • 5. Pathogenesis and screening for hepatocellular carcinoma.
    Sherman M.
    Clin Liver Dis; 2004 May; 8(2):419-43, viii. PubMed ID: 15481348
    [Abstract] [Full Text] [Related]

  • 6. Emphysema, cirrhosis, and hepatoma with alpha-1 antitrypsin deficiency.
    Lieberman J.
    Ann Intern Med; 1974 Dec; 81(6):850-2. PubMed ID: 4372921
    [No Abstract] [Full Text] [Related]

  • 7. Hepatocellular carcinoma and intermediate alpha1-antitrypsin deficiency (MZ phenotype).
    Lieberman J, Silton RM, Agliozzo CM, McMahon J.
    Am J Clin Pathol; 1975 Sep; 64(3):304-10. PubMed ID: 169686
    [Abstract] [Full Text] [Related]

  • 8. Is there a relationship between alpha-1-antitrypsin Pi MZ phenotype and hepatoma?
    Charlionet R, Martin JP, Sesboué R, Ropartz C.
    Biomedicine; 1976 Jun; 25(4):125-6. PubMed ID: 60146
    [No Abstract] [Full Text] [Related]

  • 9. Alpha-1-antitrypsin deficiency in Southern African hepatocellular carcinoma patients. An immunoperoxidase and histochemical study.
    Cohen C, Berson SD, Budgeon LR.
    Cancer; 1982 Jun 15; 49(12):2537-40. PubMed ID: 6280844
    [Abstract] [Full Text] [Related]

  • 10. Gastrointestinal aspects of alpha 1-antitrypsin deficiency.
    Braxel C, Versieck J, Barbier F.
    Acta Gastroenterol Belg; 1980 Jun 15; 43(11-12):451-63. PubMed ID: 6259867
    [No Abstract] [Full Text] [Related]

  • 11. [alpha 1-antitrypsin deficiency and liver diseases].
    von Schönfeld J, Breuer N.
    Dtsch Med Wochenschr; 1993 Dec 10; 118(49):1819-24. PubMed ID: 8253047
    [No Abstract] [Full Text] [Related]

  • 12. Does the concentration of alpha 1-proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma?
    Dabrowska M, Mantur M, Panasiuk A, Prokopowicz J.
    Neoplasma; 1997 Dec 10; 44(5):305-7. PubMed ID: 9473790
    [Abstract] [Full Text] [Related]

  • 13. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies.
    Geller SA, Nichols WS, Kim S, Tolmachoff T, Lee S, Dycaico MJ, Felts K, Sorge JA.
    Hepatology; 1994 Feb 10; 19(2):389-97. PubMed ID: 8294096
    [Abstract] [Full Text] [Related]

  • 14. Alpha-1-antitrypsin deficiency and liver disease.
    Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W.
    Dig Dis; 1994 Feb 10; 12(3):139-49. PubMed ID: 7988061
    [Abstract] [Full Text] [Related]

  • 15. No association between genetic hemochromatosis and alpha1-antitrypsin deficiency.
    Fargion S, Bissoli F, Fracanzani AL, Suigo E, Sergi C, Taioli E, Ceriani R, Dimasi V, Piperno A, Sampietro M, Fiorelli G.
    Hepatology; 1996 Nov 10; 24(5):1161-4. PubMed ID: 8903392
    [Abstract] [Full Text] [Related]

  • 16. [Alpha 1-antitrypsin and neoplasms].
    Millán Núñez-Cortés J.
    Rev Clin Esp; 1996 Nov 10; 174(3-4):65-7. PubMed ID: 6083585
    [No Abstract] [Full Text] [Related]

  • 17. Malignant liver disease in alpha 1-antitrypsin deficiency.
    Poley JR.
    Acta Paediatr Suppl; 1994 Feb 10; 393():27-32. PubMed ID: 8032114
    [No Abstract] [Full Text] [Related]

  • 18. Transgenic mouse models of hepatocellular carcinoma.
    Gordon JW.
    Hepatology; 1994 Feb 10; 19(2):538-9. PubMed ID: 8294111
    [No Abstract] [Full Text] [Related]

  • 19. Alpha-1-antitrypsin deficiency resulting in a hitherto unseen presentation of hepatocellular carcinoma: polycythemia but with normal alpha fetoprotein.
    Owen DR, Sivakumar R, Suh ES, Seevaratnam M.
    World J Gastroenterol; 2006 Aug 14; 12(30):4906-7. PubMed ID: 16937479
    [Abstract] [Full Text] [Related]

  • 20. Hepatocellular Carcinoma in a Child With Chronic Hepatitis C and α-1 Antitrypsin Heterozygosity.
    Viswanathan P, Kogan-Liberman D, Thompson JF, Schwartz D, Pan DH.
    J Pediatr Gastroenterol Nutr; 2017 Jan 14; 64(1):e22-e24. PubMed ID: 25250683
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.